Ashwagandha

Ashwagandha Extract, Powder

Products
3
NIH LiverTox — hepatotoxicity
Category B · Highly likely cause
About LiverTox →

LiverTox Category B. 2019-2024: rising case reports of idiosyncratic hepatitis. Iceland DHPA 2024 advisory; EU scrutiny ongoing. Heightened risk with existing liver disease or concurrent hepatotoxic drugs.

LiverTox record (NIH NCBI Bookshelf) →
Label dose distribution · 3 labeled products
Min
500 mg
Typical
833.333 mg
Max
1 g
Other forms of Ashwagandha

25 sibling forms

Distinct chemical forms sharing the same parent nutrient. Different UNIIs, different bioavailability, different effects — never collapsed.

Top brands carrying Ashwagandha Extract, Powder

15 brands rolled up

Products containing Ashwagandha Extract, Powder

3 in catalog